HH Biotechnology Holdings Company (HHBT) Research

HH Biotechnology Holdings Company operates within the health and green industries. Its primary activities include the cultivation and distribution of macadamia nuts, which are then utilized in a broad spectrum of products, including foodstuffs, culinary oils, wellness items, personal care products, and cosmetic formulations. The entity, originally established in 1987, was previously named Great China International Holdings, Inc. before rebranding to HH Biotechnology Holdings Company in August 2016. Its corporate headquarters are situated in Shenyang, People's Republic of China.

Market snapshot

Symbol
HHBT
Price
$0.00
Day change
0.00%
Market cap
$1.4K
P/E ratio
0.00x
52-week range
0.0001-0.0002
Sector
Real Estate
Industry
Real Estate - Services

Peer companies

  • AmeriCann, Inc. (ACAN)
  • Agritek Holdings, Inc. (AGTK)
  • Bresler & Reiner, Inc. (BRER)
  • Canal Capital Corporation PFD EXCH $1.30 (COWPP)
  • Vert Infrastructure Ltd. (CRXPF)
  • China Evergrande Group (EGRNF)
  • Eagle Hospitality Properties Trust Inc. (EHPTP)
  • Manufactured Housing Properties Inc. (MHPC)

Open HH Biotechnology Holdings Company (HHBT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.